LOKELMA

This brand name is authorized in Austria, Canada, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Italy, Japan, Lithuania, Netherlands, Poland, Romania, United Kingdom, United States

Active ingredients

The drug LOKELMA contains one active pharmaceutical ingredient (API):

1 Sodium zirconium cyclosilicate UNII D652ZWF066 - SODIUM ZIRCONIUM CYCLOSILICATE

Sodium zirconium cyclosilicate is a non-absorbed, non-polymer inorganic powder with a uniform micropore structure that preferentially captures potassium in exchange for hydrogen and sodium cations. Sodium zirconium cyclosilicate captures potassium throughout the entire gastrointestinal (GI) tract and reduces the concentration of free potassium in the GI lumen, thereby lowering serum potassium levels and increasing faecal potassium excretion to resolve hyperkalaemia. Read about Sodium zirconium cyclosilicate

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
LOKELMA Powder for oral suspension	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
V03AE10		V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AE Drugs for treatment of hyperkalemia and hyperphosphatemia
Discover more medicines within V03AE10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02490714, 02490722
Country: EE	Ravimiamet	Identifier(s): 1767573, 1767584, 1767595, 1767607, 1792841, 1792852
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 1171173002, 1171173004
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 171874, 580788
Country: FR	Base de données publique des médicaments	Identifier(s): 64247885, 64737437
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 370618, 370624, 370626
Country: HK	Department of Health Drug Office	Identifier(s): 66489, 66490
Country: IT	Agenzia del Farmaco	Identifier(s): 046335016, 046335028, 046335030, 046335042, 046335055, 046335067, 046335079, 046335081, 046335093, 046335105, 046335117, 046335129
Country: JP	医薬品医療機器総合機構	Identifier(s): 2190040B1020, 2190040B2027
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1085278, 1085279, 1085280, 1085281, 1085819, 1085820, 1088657, 1088658, 1088659, 1088660, 1088661, 1088662
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 198498, 198501
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100423163, 100423170
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W65518001, W65519001
Country: US	FDA, National Drug Code	Identifier(s): 0310-1105, 0310-1110